The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
Open accessAbstract
Data on the clinical outcomes of children with COVID-19 are scarce, particularly in those with asymptomatic and mild disease. Studies involving adults suggest that long-term multisystem sequelae and complications can occur, even with mild COVID-19. We aimed to describe medium-term clinical outcomes 3–6 months after diagnosis in children with COVID-19 presenting to a tertiary paediatric hospital. We followed children (aged ≤18 years) at a dedicated COVID-19 follow-up clinic at the Royal Children’s Hospital (RCH) in Melbourne, Australia, between March 21, 2020 and March 17, 2021. Children who tested positive for SARSCoV-2 at the RCH or externally between March 21 and Oct 28, 2020, were referred to this clinic. A standardised clinic proforma was used to collect information on acute COVID-19 symptoms, transmission risk factors, medical history, and post-acute COVID-19 symptoms (eg, dyspnoea, fatigue, rash, or abdominal pain; appendix pp 1–2). Acute disease severity was classified according to WHO criteria. Data were extracted from the RCH electronic medical record. This study was approved by the RCH Human Research and Ethics Committee (HREC QA/63103/ RCHM-2020). A total of 171 children from 137 house holds attended the clinic (appen dix p 3). Most cases of COVID-19 (136 [80%] of 171 children) were identified between July and August, 2020, corresponding with the epidemio logical peak in Melbourne during this period. There have been 3285 reported cases of COVID-19 in children and adolescents (aged 0–19 years) in Victoria to date (March 17, 2021). Our cohort comprised of 171 children (median age 3 years [IQR 1–8]): 90 (53%) boys and 81 (47%) girls. Most children had mild disease (100 [58%]) or were asymptomatic (61 [36%]), and nine (5%) children had moderate disease. The few hospital admissions (14 [8%] children) were generally brief and were for observation or fluid rehydration. One (1%) child with complex congenital heart disease had severe COVID-19 pneumonitis with acute respiratory failure (appendix p 3). Two (1%) children had postacute COVID-19 inflammatory conditions temporally associated with SARS-CoV-2: a 7-year-old child with paediatric multisystem inflammatory syndrome who required intensive care management, and an 11-month-old child with Kawasaki disease. Follow-up data at 3–6 months were available for 151 (88%) of 171 children, of whom 54 (36%) were asymptomatic and 97 (64%) were symptomatic (ie, with mild, moderate, or severe disease) with acute COVID-19. 12 (8%) children had post-acute COVID-19 symptoms, all of whom were symptomatic with acute COVID-19 (table). The most common post-acute COVID-19 symptoms were mild post-viral cough (six [4%] of 151 children), fatigue (three [2%] children) or both postviral cough and fatigue (one [1%] child). The duration of post-viral cough ranged from 3 weeks to 8 weeks and of post-viral fatigue ranged from 6 weeks to 8 weeks from the time of symptom onset. At the most recent review in March, 2021, all 151 children had returned to their baseline health status and post-acute COVID-19 symptoms had resolved. Follow-up data for 20 children were not available; seven (35%) of these children had asymptomatic COVID-19. These findings contrast those of studies of COVID-19 in adults, which have identified multisystem complications and a higher prevalence and severity of persistent symptoms. Common complications in adults are respiratory sequelae and persistent fatigue (eg, residual dyspnoea ranging from 11% to 43% and fatigue ranging from 35% to 64%). In our paediatric cohort, full recovery occurred within weeks of acute symptom onset and reported symptoms were mild in severity. This study was done at a single centre in a metropolitan tertiary paediatric hospital with predominantly young (median age 3 years [IQR 1–8]) children, which could limit the generalisability of results. Our cohort included a large proportion of
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Cited by
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554
Collaborators, G. B. O. D. L. C., Wulf Hanson, S., Abbafati, C., Aerts, J. G., Al-Aly, Z., Ashbaugh, C., Ballouz, T., Blyuss, O., Bobkova, P., Bonsel, G., et al. (2022) · JAMA · doi:10.1001/jama.2022.18931 · Cited by 970
Long-COVID in children and adolescents: a systematic review and meta-analyses
Lopez-Leon, S., Wegman-Ostrosky, T., Ayuzo del Valle, N. C., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13495-5 · Cited by 528
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
Molteni, E., Sudre, C. H., Canas, L. S., Bhopal, S. S., Hughes, R. C., Antonelli, M., Murray, B., Kläser, K., Kerfoot, E., Chen, L., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00198-x · Cited by 421
Osmanov, I. M., Spiridonova, E., Bobkova, P., Gamirova, A., Shikhaleva, A., Andreeva, M., Blyuss, O., El-Taravi, Y., DunnGalvin, A., Comberiati, P., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01341-2021 · Cited by 342
Metadata
- Authors
- Say, D., Crawford, N., McNab, S., Wurzel, D., Steer, A., & Tosif, S.
- Venue
- The Lancet Child & Adolescent Health
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 5
- Issue
- 6
- Pages
- e22-e23
- ISSN
- 2352-4642 (ISSN-L)
- OpenAlex
- W3156527147
- Cited by
- 205
- References
- 1
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. https://app.cochat.ai/papers/10.1016/s2352-4642(21)00124-3
- The paper
- Say, D., Crawford, N., McNab, S., Wurzel, D., Steer, A., & Tosif, S. (2021). Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(21)00124-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.